Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

An elderly Chinese man lost all his hair after taking a new heart medication.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Abatacept may help some people with alopecia areata regrow hair.